Literature DB >> 2102354

The number of nucleoli in benign and malignant thyroid lesions: a useful diagnostic sign in cytological preparations.

R Montironi1, A Braccischi, M Scarpelli, S Sisti, G Matera, G M Mariuzzi, R Alberti, Y Collan.   

Abstract

The slides of fine needle aspiration cytology specimens from 99 cases of cold thyroid nodules with known histology were reviewed and the number of nucleoli per nucleus counted and correlated with the different histopathological groups. Significant differences were observed between benign and malignant thyroid lesions in the number of nucleoli in the cytological material. Lower values were present in nodular goitres and follicular adenomas compared to carcinomas. In benign lesions the majority of nuclei contained one nucleolus and nuclei with two, three or more nucleoli were less frequent than in follicular, papillary, medullary and anaplastic carcinomas. Only one case of follicular adenoma had cells containing three or more nucleoli compared to more than half the cases of follicular carcinoma.

Entities:  

Mesh:

Year:  1990        PMID: 2102354     DOI: 10.1111/j.1365-2303.1990.tb00341.x

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  3 in total

1.  Contribution of fine needle aspiration cytology to diagnosis and management of thyroid disease.

Authors:  L Godinho-Matos; G Kocjan; A Kurtz
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

2.  Quantitative analysis of nucleolar margination in diagnostic cytopathology.

Authors:  R Montironi; M Scarpelli; A Braccischi; C Magi Galluzzi; L Diamanti; R Alberti
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  RRS1 gene expression involved in the progression of papillary thyroid carcinoma.

Authors:  Feng Chen; Yaqiong Jin; Lin Feng; Jie Zhang; Jun Tai; Jin Shi; Yongbo Yu; Jie Lu; Shengcai Wang; Xin Li; Ping Chu; Shujing Han; Shujun Cheng; Yongli Guo; Xin Ni
Journal:  Cancer Cell Int       Date:  2018-02-13       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.